Lucia Hans to Pyridones
This is a "connection" page, showing publications Lucia Hans has written about Pyridones.
Connection Strength
0,756
-
Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries. AIDS. 2023 05 01; 37(6):1009-1011.
Score: 0,198
-
Compelling evidence for unconditional shift to dolutegravir. Lancet HIV. 2022 08; 9(8):e523-e524.
Score: 0,191
-
Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. Pediatr Infect Dis J. 2022 10 01; 41(10):827-834.
Score: 0,191
-
Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa. J Int AIDS Soc. 2021 05; 24(5):e25706.
Score: 0,176